Literature DB >> 8848190

MRI in patients with suspected vascular parkinsonism.

J C Zijlmans1, H O Thijssen, O J Vogels, H P Kremer, P J Poels, H C Schoonderwaldt, J L Merx, M A van 't Hof, T Thien, M W Horstink.   

Abstract

To determine whether MRI can reveal more vascular lesions in patients clinically suspected of having vascular parkinsonism, we compared 15 such patients with 15 patients who had idiopathic Parkinson's disease and 10 hypertensive controls. Patients with suspected vascular parkinsonism had significantly more subcortical lesions than those with Parkinson's disease or hypertension. The cutoff point that best distinguished patients with suspected vascular parkinsonism from patients with Parkinson's disease was a 0.6% level of lesioned brain tissue volume. There were two types of vascular parkinsonism: one had an acute onset and lesions located in the subcortical gray nuclei (striatum, globus pallidus, thalamus); the other had an insidious onset and lesions diffusely distributed in the watershed areas.

Entities:  

Mesh:

Year:  1995        PMID: 8848190     DOI: 10.1212/wnl.45.12.2183

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  The L-dopa response in vascular parkinsonism.

Authors:  J C M Zijlmans; R Katzenschlager; S E Daniel; A J L Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

2.  Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases.

Authors:  M Plotkin; H Amthauer; S Quill; F Marzinzik; F Klostermann; S Klaffke; A Kivi; M Gutberlet; R Felix; A Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2005-02-22       Impact factor: 3.575

3.  Association of vascular parkinsonism with impaired neuronal integrity in the striatum.

Authors:  M Ihara; H Tomimoto; K Ishizu; H Yoshida; N Sawamoto; K Hashikawa; H Fukuyama
Journal:  J Neural Transm (Vienna)       Date:  2007-01-18       Impact factor: 3.575

4.  Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.

Authors:  Megan K Herbert; H Bea Kuiperij; Bastiaan R Bloem; Marcel M Verbeek
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

5.  MRI volumetric morphometry in vascular parkinsonism.

Authors:  Vincent Dunet; Jeremy Deverdun; Celine Charroud; Emmanuelle Le Bars; Francois Molino; Sophie Menjot de Champfleur; Florence Maury; Mahmoud Charif; Xavier Ayrignac; Pierre Labauge; Giovanni Castelnovo; Frederic Pinna; Alain Bonafe; Christian Geny; Nicolas Menjot de Champfleur
Journal:  J Neurol       Date:  2017-07-01       Impact factor: 4.849

6.  Cognitive Impairment and Basal Ganglia Functional Connectivity in Vascular Parkinsonism.

Authors:  V Dunet; J Deverdun; C Charroud; E Le Bars; F Molino; S Menjot de Champfleur; F Maury; M Charif; X Ayrignac; P Labauge; G Castelnovo; F Pinna; A Bonafe; C Geny; N Menjot de Champfleur
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-14       Impact factor: 3.825

Review 7.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

8.  Post-stroke movement disorders: report of 56 patients.

Authors:  F Alarcón; J C M Zijlmans; G Dueñas; N Cevallos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

9.  Impact of subcortical white matter lesions on dopamine transporter SPECT.

Authors:  Elisabeth Funke; Andreas Kupsch; Ralph Buchert; Winfried Brenner; Michail Plotkin
Journal:  J Neural Transm (Vienna)       Date:  2013-01-24       Impact factor: 3.575

10.  Subacute hemicorporal parkinsonism in 5 patients with infarcts of the basal ganglia.

Authors:  J Vaamonde; J M Flores; M J Gallardo; R Ibáñez
Journal:  J Neural Transm (Vienna)       Date:  2007-08-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.